NASDAQ: ARQT
Arcutis Biotherapeutics Inc Stock Ownership - Who owns Arcutis Biotherapeutics?

Insider buying vs selling

Have Arcutis Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Patrick BurnettReporting Persons Title Executive Vice President and Chief Medical Officer2025-08-212,438$15.57
$37.97kSell
Patrick BurnettReporting Persons Title Executive Vice President and Chief Medical Officer2025-08-191,750$16.16
$28.28kSell
Patrick BurnettReporting Persons Title Executive Vice President and Chief Medical Officer2025-08-083,847$14.03
$53.99kSell
Todd WatanabeReporting Persons title President and Chief Executive Officer2025-08-0411,547$14.33
$165.43kSell
Patrick BurnettReporting Persons Title Executive Vice President and Chief Medical Officer2025-08-042,622$14.33
$37.57kSell
Masaru MatsudaReporting Persons title SVP General Counsel and Corporate Secretary2025-08-046,330$14.33
$90.69kSell
Latha VairavanSVP Chief Financial Officer2025-08-0489$14.33
$1.28kSell
Howard G. WelgusDirector2025-08-013,890$14.30
$55.62kSell
Howard G. WelgusDirector2025-08-016,110$14.30
$87.36kSell
Patrick BurnettReporting Persons Title Executive Vice President and Chief Medical Officer2025-07-145,750$15.07
$86.65kSell

1 of 7

ARQT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ARQT insiders and whales buy or sell their stock.

ARQT Shareholders

What type of owners hold Arcutis Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Patrick J. Heron16.20%19,430,454$304.09MInsider
Suvretta Capital Management LLC9.62%11,535,582$180.53MInstitution
Jennison Associates LLC9.27%11,109,405$173.86MInstitution
Rubric Capital Management LP8.96%10,749,457$168.23MInstitution
Frazier Life Sciences Management LP8.24%9,874,511$154.54MInstitution
Frazier Life Sciences VIII LP7.37%8,838,534$138.32MInsider
Blackrock Inc7.12%8,532,761$133.54MInstitution
Vanguard Group Inc5.88%7,049,099$110.32MInstitution
Polar Capital Holdings PLC4.18%5,006,475$78.35MInstitution
State Street Corp3.78%4,526,937$70.85MInstitution

1 of 3

ARQT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARQT76.76%23.24%Net SellingNet Selling
MESO0.30%0.00%
VCEL91.49%8.51%Net SellingNet Buying
SRPT74.07%25.93%Net SellingNet Selling
BCRX84.08%15.92%Net SellingNet Buying

Arcutis Biotherapeutics Stock Ownership FAQ

Who owns Arcutis Biotherapeutics?

Arcutis Biotherapeutics (NASDAQ: ARQT) is owned by 105.94% institutional shareholders, 32.08% Arcutis Biotherapeutics insiders, and 0.00% retail investors. Patrick J. Heron is the largest individual Arcutis Biotherapeutics shareholder, owning 19.43M shares representing 16.20% of the company. Patrick J. Heron's Arcutis Biotherapeutics shares are currently valued at $300.98M.

If you're new to stock investing, here's how to buy Arcutis Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.